First Trust Advisors’s NovoCure NVCR Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$2.71M Buy
+152,273
New +$2.71M ﹤0.01% 1682
2023
Q1
Sell
-78,639
Closed -$5.77M 2439
2022
Q4
$5.77M Buy
78,639
+71,782
+1,047% +$5.27M 0.01% 1130
2022
Q3
$521K Buy
+6,857
New +$521K ﹤0.01% 2194
2022
Q1
Sell
-27,455
Closed -$2.06M 2573
2021
Q4
$2.06M Sell
27,455
-211,948
-89% -$15.9M ﹤0.01% 1781
2021
Q3
$27.8M Buy
239,403
+156,541
+189% +$18.2M 0.03% 655
2021
Q2
$18.4M Sell
82,862
-111,914
-57% -$24.8M 0.02% 814
2021
Q1
$25.7M Sell
194,776
-73,732
-27% -$9.75M 0.03% 621
2020
Q4
$46.5M Buy
+268,508
New +$46.5M 0.06% 439
2020
Q3
Sell
-43,744
Closed -$2.59M 2423
2020
Q2
$2.59M Sell
43,744
-22,248
-34% -$1.32M ﹤0.01% 1250
2020
Q1
$4.44M Sell
65,992
-10,472
-14% -$705K 0.01% 910
2019
Q4
$6.44M Sell
76,464
-15,520
-17% -$1.31M 0.01% 992
2019
Q3
$6.88M Sell
91,984
-4,959
-5% -$371K 0.01% 935
2019
Q2
$6.13M Sell
96,943
-2,070
-2% -$131K 0.01% 955
2019
Q1
$4.77M Sell
99,013
-8,533
-8% -$411K 0.01% 1042
2018
Q4
$3.6M Sell
107,546
-67,662
-39% -$2.27M 0.01% 1146
2018
Q3
$9.18M Buy
175,208
+32,543
+23% +$1.71M 0.02% 863
2018
Q2
$4.47M Buy
142,665
+28,341
+25% +$887K 0.01% 1155
2018
Q1
$2.49M Sell
114,324
-29,831
-21% -$650K 0.01% 1337
2017
Q4
$2.91M Buy
+144,155
New +$2.91M 0.01% 1286